Search Results for "Orthophoenix Llc Medtornic Kyphon Patents"

09:20 EDT 28th July 2015 | BioPortfolio

Matching Channels

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...

Tumor Necrosis Factor TNF Products

Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...

Coagulation Factors

Fourteen different blood coagulation factors are present in the body. Each plays a crucial role in the process described above. Some work to increase the activity level of the other factors while so...

Matching News

Suven secures three product patents for their NCEs in Canada, Japan and Korea

Biospectrum With these new patents, Suven has a total of 18 granted patents from Canada, 16 granted patents from Japan,...

Valencell Expands Robust Portfolio of Critical Patents

Valencell, a leader in performance biometric data sensor technology, today announced it has been granted an additional eight patents by the United States Patent and Trademark Office. The new patents a...

Carestream Awarded 66 U.S. Patents In 2014

Carestream Health was awarded 66 new patents from the U.S. Patent and Trademark Office in 2014 for innovations in radiology imaging, healthcare IT, dental imaging and other areas, reflecting another s...

Ocata gets three new US patents for RPE therapy for macular degenerative diseases

Ocata Therapeutics, a leader in the field of Regenerative Ophthalmology, announced that the US Patent and Trademark Office (USPTO) issued three new US Patents, Nos. 9,040,770, 9,040,039 and 9,040,038,...

Are Software Patents Dead?—Alice’s Implications for Life Sciences

Not too long ago, getting patents on software and business methods was all the rage. And concern about their effects was profound. In fact, in 2003 I spoke at a Federal Reserve Bank conference devoted...

BRIEF-Crossject announces five new patents

* All patents linked with optimization of Zeneo in the framework of the industrialization of this product

Suven Life Sciences granted new patents

Patents cover drugs for treating neurodegenerative disorders

Patents forecast technological change

(Massachusetts Institute of Technology) Engineers at MIT have devised a formula for estimating how fast a technology is advancing, based on information gleaned from relevant patents.

Matching PubMed Articles

The importance of patents to innovation: updated cross-industry comparisons with biopharmaceuticals.

Patents have long been considered essential incentives to foster innovation, particularly the development of new prescription drugs, due to the lengthy, costly, and risky nature of the research and de...

Stem Cell Patents after the America Invents Act.

Under the newly passed Leahy-Smith America Invents Act (AIA), the U.S. Patent and Trademark Office may hear new challenges to stem cell patents. Here, we explore how the new law affects challenges to ...

Quantifying innovation in surgery.

The objectives of this study were to assess the applicability of patents and publications as metrics of surgical technology and innovation; evaluate the historical relationship between patents and pub...

Dendritic-cell-based technology landscape: Insights from patents and citation networks.

As the most potent antigen-presenting cells, dendritic cells (DCs) are pivotal players in regulating immune responses. DC-based technologies have generated a series of typical and promising therapeuti...

Newer patents in antimycobacterial therapy.

Tuberculosis caused by Mycobacterium tuberculosis is a global health emergency. This deadly disease has far-reaching social and economic implications. Diseased individuals need prolonged polypharmacy ...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement